Trialt, a global clinical research organization (CRO) specializing in biostatistics, data management, and medical writing, has announced a strategic collaboration with Viedoc, a provider of cloud-based eClinical solutions.  

The partnership aims to accelerate clinical trial timelines, boost data quality, and improve decision-making for sponsors worldwide. 

“This collaboration brings together two complementary strengths,” the companies said.  

Viedoc provides efficient study execution and data collection, while Trialt adds deep biometrics expertise, ensuring data flows seamlessly into analysis, interpretation, and submission. The goal: a more connected experience where data collection and insight work in harmony, letting teams spend less time resolving issues and more time advancing their studies. 

“Clinical trials succeed when data, technology, and expertise work together,” said Yaroslav Sud, Vice President of Biometrics at Trialt. “Working with Viedoc allows us to support Sponsors with a clear path from data capture through analysis. That alignment helps teams move faster and make stronger decisions throughout the study.” 

The collaboration supports a wide range of studies, including global and decentralized trials where visibility and coordination are critical. Early alignment of data capture with downstream biometrics reduces rework, improves data quality, and keeps programs on track. 

“At Viedoc, we believe strong partnerships are key to delivering successful clinical trials,” said Adam Alsén, Business Development Manager at Viedoc. “By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational know-how needed to run efficient, high-quality studies with confidence.”